Archive
All News
Every briefing, headline, and filing we've published, newest first.
PipelineFierceBiotech ↗
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundre…
DataFierceBiotech ↗
Clinical site selection platform RyghtAI has launched a search engine designed to give drug developers and con…
PipelineFierceBiotech ↗
Qiagen has moved into syndromic testing for bloodstream infections with the launch of its newest offering.…
PipelineFierceBiotech ↗
While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public healt…
The WeekFierceBiotech ↗
Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, G…
The WeekFierceBiotech ↗
Clinical trial site network Rare Disease Research (RDR) is partnering with health tech company myTomorrows to …
PolicyBriefing
Viatris pulled one lot of extended-release Xanax, and Teva recalled multiple lots of clonidine patches over co…
Data
New DCI data show hospitals now run nearly one-third of accredited specialty pharmacies, while payer groups re…
Negotiations
The 2026 FTC settlement compels Express Scripts to base patient costs on net, not list, prices—ending the reba…
Negotiations
AssistRx says half of its 2025 patient support programs came via hub transitions, underscoring deep vendor con…
NegotiationsBriefing
The 2026 exclusion lists from Caremark, Express Scripts, and Optum Rx favor private-label biosimilars and lowe…
PolicyFiercePharma ↗
The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing …
MoneyFierceBiotech ↗
A slow start to 2026 has put first-time biotech financings on course for their worst year since before the pan…
PeopleBriefing
Matthew Lang, who steered Metsera’s $10B sale to Pfizer, joins Structure Therapeutics as COO and GC, as Vir an…
PeopleBriefing
Astellas trims stem cell research, GSK accelerates its ADC program, Daiichi exits OTC, Takeda ends mRNA pact, …
DataBriefing
New KFF data show 165.6M Americans under 65 had employer coverage in March 2025, yet only 22.5% of those below…
PeopleFiercePharma ↗
AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board of directors as the link betwe…
PolicyFiercePharma ↗
The FDA should strengthen the evidence required for drug approvals under its accelerated pathway, and increase…
DealsFiercePharma ↗
With Daiichi Sankyo’s priorities increasingly tied to its innovative medicines—and its oncology portfolio in p…
NegotiationsFiercePharma ↗
A prominent physician voice in the House of Representatives has introduced a new bill that would compel insure…
PipelineFierceBiotech ↗
More than a year after licensing its PD-1xVEGF bispecific, Merck & Co. has finally unveiled the first clin…
MoneyFierceBiotech ↗
Abbott's first-quarter numbers reflect is operational complexity.…
MoneyFierceBiotech ↗
Terremoto Biosciences has spelt out how the California biotech will use a $108 million series C round to conti…
MoneyFierceBiotech ↗
The Spanish government has announced a goal to raise a $200 million venture capital fund to launch the Spain-B…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.